Literature DB >> 30247470

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury.

Allyson L Huttinger1, Debra G Wheeler1, Surya Gnyawali2, David Dornbos1, Juliana M Layzer3, Nicholas Venetos1, Spencer Talentino1, Nicholas J Musgrave1, Cheyenne Jones1, Camille Bratton1, Matthew E Joseph4, Chandan Sen2, Bruce A Sullenger3, Shahid M Nimjee5.   

Abstract

Occlusive arterial thrombosis leading to cerebral ischemic stroke and myocardial infarction contributes to ~13 million deaths every year globally. Here, we have translated a vascular injury model from a small animal into a large animal (canine), with slight modifications that can be used for pre-clinical screening of prophylactic and thrombolytic agents. In addition to the surgical methods, the modified protocol describes the step-by-step methods to assess carotid artery canalization by angiography, detailed instructions to process both the brain and carotid artery for histological analysis to verify carotid canalization and cerebral hemorrhage, and specific parameters to complete an assessment of downstream thromboembolic events by utilizing magnetic resonance imaging (MRI). In addition, specific procedural changes from the previously well-established small animal model necessary to translate into a large animal (canine) vascular injury are discussed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30247470      PMCID: PMC6235140          DOI: 10.3791/57981

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  19 in total

Review 1.  Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents.

Authors:  R J Leadley; L Chi; S S Rebello; A Gagnon
Journal:  J Pharmacol Toxicol Methods       Date:  2000 Mar-Apr       Impact factor: 1.950

Review 2.  In vivo thrombus formation in murine models.

Authors:  Ulrich J H Sachs; Bernhard Nieswandt
Journal:  Circ Res       Date:  2007-04-13       Impact factor: 17.367

3.  Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel.

Authors:  Thomas Bonnard; Christoph E Hagemeyer
Journal:  J Vis Exp       Date:  2015-06-29       Impact factor: 1.355

4.  Thrombotic distal middle cerebral artery occlusion produced by topical FeCl(3) application: a novel model suitable for intravital microscopy and thrombolysis studies.

Authors:  Hulya Karatas; Sefik Evren Erdener; Yasemin Gursoy-Ozdemir; Gunfer Gurer; Figen Soylemezoglu; Andrew K Dunn; Turgay Dalkara
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-16       Impact factor: 6.200

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis.

Authors:  Maarten G Lansberg; Erich Bluhmki; Vincent N Thijs
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

Review 7.  Animal models of thrombosis.

Authors:  Peter F Bodary; Daniel T Eitzman
Journal:  Curr Opin Hematol       Date:  2009-09       Impact factor: 3.284

8.  Ferric chloride-induced murine carotid arterial injury: A model of redox pathology.

Authors:  Wei Li; Thomas M McIntyre; Roy L Silverstein
Journal:  Redox Biol       Date:  2013-01-26       Impact factor: 11.799

9.  Diffusion-Weighted Imaging Using a Readout-Segmented, Multishot EPI Sequence at 3 T Distinguishes between Morphologically Differentiated and Undifferentiated Subtypes of Thyroid Carcinoma-A Preliminary Study.

Authors:  Stefan Schob; Peter Voigt; Lionel Bure; Hans-Jonas Meyer; Claudia Wickenhauser; Curd Behrmann; Annekathrin Höhn; Paul Kachel; Henning Dralle; Karl-Titus Hoffmann; Alexey Surov
Journal:  Transl Oncol       Date:  2016-09-20       Impact factor: 4.243

10.  Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.

Authors:  Stefan Schob; Jonas Meyer; Matthias Gawlitza; Clara Frydrychowicz; Wolf Müller; Matthias Preuss; Lionel Bure; Ulf Quäschling; Karl-Titus Hoffmann; Alexey Surov
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

View more
  3 in total

1.  Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels.

Authors:  Shahid M Nimjee; David Dornbos; George A Pitoc; Debra G Wheeler; Juliana M Layzer; Nicholas Venetos; Allyson Huttinger; Spencer E Talentino; Nicholas J Musgrave; Holly Moody; Rachel E Rempel; Cheyenne Jones; Kendyl Carlisle; Jenna Wilson; Camille Bratton; Matthew E Joseph; Shoeb Khan; Maureane R Hoffman; Laura Sommerville; Richard C Becker; Jay L Zweier; Bruce A Sullenger
Journal:  Mol Ther       Date:  2019-03-30       Impact factor: 11.454

2.  The Antithrombotic Effect of Recombinant Neorudin on Thrombi.

Authors:  Yu-Bin Liu; Lin Zhang; Xing-Chen Zhou; Ying Zhou; Yun Liu; Can Zheng; Xiao Xu; Pan-Pan Geng; Chun-Hua Hao; Zhuan-You Zhao; Chu-Tse Wu; Ji-De Jin
Journal:  Drug Des Devel Ther       Date:  2022-06-02       Impact factor: 4.319

Review 3.  Theranostic nanoparticles for the management of thrombosis.

Authors:  Peije Russell; Christoph Eugen Hagemeyer; Lars Esser; Nicolas Hans Voelcker
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.